Patent Expiry
TVTX: Patent_Expiry: NDA216403
September 5, 2031 · SPARSENTAN. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 5, 2031
- Company
- Travere Therapeutics, Inc. (TVTX)
- Drug
- SPARSENTAN
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
Patent_Expiry: NDA216403
Orange Book application NDA216403, product 001; overall loss of exclusivity is unverified. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- SPARSENTAN